# identity.md

## Organization Overview
- **Company Name:** Insilico Medicine
- **Mission:** To accelerate drug discovery and development by leveraging a proprietary, end-to-end generative AI-driven platform (Pharma.AI) across biology, chemistry, and clinical development.
- **Company Structure and Legal Entity:** Details forthcoming.
- **Founded Date and Location:** Details forthcoming.
- **Size and Scale:** A globally leading end-to-end generative AI-driven biotech company in terms of AIDD pipeline progress.

## Leadership & Team
- **Key Leadership Profiles and Roles:** Alex Zhavoronkov, PhD: Founder, Chairman of the Board, Executive Director, and CEO. [Profile Link](https://scholar.google.com/citations?hl=en&user=8Icccp0AAAAJ&view_op=list_works&sortby=pubdate)
- **Team Structure and Departments:** Details forthcoming.
- **Company Culture and Values:** Focus on generative AI and automation for longevity and sustainability.

## Operations & Structure
- **Business Model and Operational Approach:** Operates as an end-to-end generative AI-driven biotech company utilizing the Pharma.AI platform. Key products include PandaOmics, PandaOmics Box, Chemistry42, Generative Biologics, Science42: DORA, and inClinic.
- **Location(s) and Geographic Presence:** Global presence.
- **Key Partnerships and Affiliations:** Details forthcoming.